Table 4.
Sensitivity analysis of the prevalence of contraceptive use among HIV positive women in Ethiopia.
| Study omitted | Prevalence | 95% CI |
|---|---|---|
| Derek et al. (2019) | 58.82 | 49.42-68.23 |
| Kebede et al. (2019) | 57.57 | 47.79-67.36 |
| Kebede et al. (2015) | 56.54 | 46.94-66.14 |
| Alene and Atalell (2018) | 59.33 | 50.59-68.07 |
| Mersha et al. (2019) | 55.78 | 47.13-64.43 |
| Melaku YA and Zeleke EG (2014) | 58.53 | 48.99-68.07 |
| Berhane et al. (2013) | 58.42 | 48.87-67.97 |
| Lemeneh T. (2016) | 56.07 | 47.12-65.03 |
| Mitiku K. (2017) | 57.43 | 47.74-67.11 |
| Demissie and Tolossa (2014) | 57.54 | 47.86-67.21 |
| Ayalew et al. (2019) | 58.85 | 49.41-68.29 |
| Zewdie et al. (2020) | 57.20 | 47.46-66.94 |
| Abeje and Motbaynor (2016) | 58.45 | 48.89-68.02 |
| Asfaw and Gashe (2014) | 57.03 | 46.94-67.12 |
| Polisi et al. (2014) | 57.84 | 48.18-67.49 |
| Abubeker et al. (2019) | 59.12 | 49.78-68.45 |
| Lemma and Mekonnen (2014) | 57.78 | 48.12-67.45 |
| Worke et al. (2016) | 58.19 | 48.58-67.79 |
| Sufa A. (2013) | 57.29 | 47.58-67.01 |